Pfizer hikes 2021 outlook after vaccine boosts sales, profit

Jul 28, 2021, 4:05 AM | Updated: 11:31 am

Strong sales of its COVID-19 vaccine and other medicines helped Pfizer nearly double its second-quarter revenue and boost its profit an impressive 59%, beating Wall Street expectations and leading the drug giant to sharply hike its 2021 sales and profit forecasts.

Amid the surging coronavirus pandemic, the COVID-19 vaccine became Pfizer’s top seller, bringing in nearly half its revenue — $7.84 billion from direct sales and revenue split with its partner, Germany’s BioNTech.

Pfizer now anticipates revenue from the two-dose vaccine this year to reach $33.5 billion for the 2.1 billion doses it’s contracted to provide by year end. That doesn’t include a contract struck last week to provide an additional 200 million doses to the U.S.

The New York company on Wednesday disclosed that ongoing testing of a booster shot, given six months after the second vaccine dose, showed it raised antibody levels against the more-transmissible Delta variant to 11 times higher in older people and five times higher in younger people, compared to levels after two doses. The company also released data showing that six months after vaccination, the shots were 97% effective in preventing severe disease.

“We are quite convinced that a booster will be needed,” CEO Albert Bourla said in an interview, adding that a third dose of the original vaccine could be sufficient. Still, Pfizer in August will start testing in volunteers a booster targeting the Delta variant, because “there’s so much at stake, you can’t take risks.”

Pfizer has delivered more than 1 billion doses of the vaccine globally and expects to make 3 billion doses this year, with many more going to low- and middle-income countries from now through year’s end, Bourla said. Most doses of all the COVID-19 vaccines produced in Europe and the U.S. so far have gone to wealthy countries.

By the end of September, testing in 5- through 11-year-old volunteers should produce the safety and efficacy data needed to seek emergency use authorization in that age group, and data on testing in children from 6 months to 5 years old should follow soon after, according to Pfizer.

The U.S. Food and Drug Administration is now reviewing data that could lead to full approval of the vaccine for adults, which Bourla said might reduce hesitancy to be vaccinated.

Second-quarter net income was $5.56 billion, or 98 cents per share, up from $3.49 billion, or 62 cents per share.

Adjusted income, excluding one-time gains and losses, amounted to $6.08 billion, or $1.07 per share, well above the 97 cents that Wall Street had expected.

Its quarterly revenue of $18.98 billion far exceeded last year’s $9.86 billion, and also topped projections.

Pfizer shares rose $1.46, or 3.5%, to $43.56, near a 52-week high.

Sales jumped by double digits for Pfizer’s drugs for cancer and rare diseases, as well as its medicines primarily used in hospitals. Sales of Eliquis, for preventing blood clots and strokes, jumped 16% to $1.48 billion, while Ibrance sales edged up 4% to $1.4 billion in the quarter.

Pfizer’s pneumonia vaccine Prevnar 13 — until now the world’s most lucrative vaccine — saw sales climb 11% to $1.24 billion amid the pandemic. The company won U.S. approval in June for an updated version for adults, Prevnar 20, that protects against seven more strains of pneumococcal disease.

In May, Pfizer and partner Myovant got approval for Myfembree, for reducing heavy menstrual bleeding due to uterine fibroids in premenopausal women.

Pfizer research head Mikael Dolsten outlined eight major research programs with potential for major impact on public health, including a pill to treat COVID-19 and vaccines against Lyme disease and respiratory syncytial virus, which each year infects more than 5% of older adults and kills about 15,000 of them in the U.S.

Pfizer now expects adjusted full-year earnings in the range of $3.95 to $4.05 per share, up from its May forecast of $3.55 to $3.65 per share, and revenue in the range of $78 billion to $80 billion, up from $70.5 billion to $72.5 billion.

_____

Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

FILE - Members of the Supreme Court pose for a group photo at the Supreme Court in Washington, Apri...
Associated Press

Supreme Court keeping live audio as it opens again to public

WASHINGTON (AP) — The Supreme Court says it will continue providing live audio broadcasts of arguments in cases, even as it welcomes the public back to its courtroom for a new term that begins Monday. The justices began providing live audio of arguments after the court closed to the public in March of 2020 because […]
15 hours ago
Associated Press

OU Health ceasing some gender care after funds threatened

OKLAHOMA CITY (AP) — The University of Oklahoma Medical Center confirmed Wednesday it is planning to stop offering some gender-affirming medical treatments after state lawmakers threatened to withhold millions of dollars in federal funding earmarked for the University Hospitals Authority. The Republican-controlled Legislature, which returned for a special session on Wednesday to appropriate $1.87 in […]
15 hours ago
A CSX freight train runs through a crossing in Homestead, Pa., Wednesday, Sept. 14, 2022. (AP Photo...
Associated Press

Rail unions emphasize positives of their tentative deals

OMAHA, Neb. (AP) — The two biggest U.S. railroad unions were working Wednesday ahead of key ratification votes to dispel rumors about the contract deals that averted a potentially devastating nationwide strike . The unions have been fighting rumors on social media that they would impose the deals on workers if they vote to reject […]
15 hours ago
Debris of a railway depot ruined after a Russian rocket attack in Kharkiv, Ukraine, Wednesday, Sept...
Associated Press

US: Focus new Russia sanctions on oil revenue, arms supplies

WASHINGTON (AP) — Future sanctions over President Vladimir Putin’s invasion of Ukraine must focus on depriving Putin of what he needs to fund and fight the war: revenue from Russia’s oil and gas sales and access to global supply networks to replenish his military, two architects of the Biden administration’s sanctions campaign told lawmakers on […]
15 hours ago
Associated Press

2 men arrested in robbery of pastor during church service

NEW YORK (AP) — Two men were arrested Wednesday for the robbery of a flashy Brooklyn pastor who was delivering a sermon in July about keeping faith when gun-toting masked men crashed the service and stole over $1 million in jewelry from the pastor and his wife. The men processed in Brooklyn federal court were […]
15 hours ago
Associated Press

Jurors must decide how much Newtown families suffering worth

WATERBURY, Conn. (AP) — After watching days of testimony that included the parents of slain children breaking down on the witness stand, a Connecticut jury soon will have the difficult task of coming up with a dollar amount that conspiracy theorist Alex Jones should pay for promoting the idea that the Sandy Hook school shooting […]
15 hours ago

Sponsored Articles

...
SCHWARTZ LASER EYE CENTER

Key dates for Arizona sports fans to look forward to this fall

Fall brings new beginnings in different ways for Arizona’s professional sports teams like the Cardinals and Coyotes.
(Courtesy Condor)...
Condor Airlines

Condor Airlines shows passion for destinations from Sky Harbor with new-look aircraft

Condor Airlines brings passion to each flight and connects people to their dream destinations throughout the world.
...
Day & Night Air Conditioning, Heating and Plumbing

Most plumbing problems can be fixed with regular maintenance

Instead of waiting for a problem to happen, experts suggest getting a head start on your plumbing maintenance.
Pfizer hikes 2021 outlook after vaccine boosts sales, profit